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Introduction: Anemia is common in patients with heart failure (HF). A recent meta-analysis reported 48% mortality rate in anemic HF patients 
compared with 29.5% for non-anemic HF patients. We conducted a retrospective study to investigate outcomes in patients with HF and anemia 
receiving packed red blood cell (PRBC) transfusion following intensive care unit (ICU) admission to those that do not receive PRBC.
Methods: Three hundred fifty two patients (age >= 18 years) were identified from the Project IMPACT® database that were admitted to the ICU 
from August 2003 through June 2010 with HF recorded as admission diagnosis. After applying the hospital laboratory-based low limit for hematocrit 
based on sex (female [37.0%]; male [42.0%]), 310 patients were identified as anemic. Forty two of these 310 patients received PRBC transfusion. 
Outcomes studied were 30-day or in-hospital mortality, mechanical ventilation (MV), duration of MV, ICU length-of-stay (LOS), and in-hospital LOS 
(HOS LOS).
Results: The PRBC group was significantly more likely to be mechanically ventilated (p<0.00), to have longer ICU LOS (p<0.00), HOS LOS (p<0.00) 
and have more days on mechanical ventilation (p<0.00). Packed red blood cell transfusion however was not associated with increased in-hospital or 
30-day mortality (p=0.70).
Conclusion: Patients with HF and anemia receiving PRBC transfusion following ICU admission have significantly increased risk of adverse outcomes 
(30-day or in-hospital mortality, MV, duration of MV, ICU LOS, HOS LOS) than patients with HF and anemia that do not receive PRBC following ICU 
admission.
